Mahnomen Health Center | |
414 West Jefferson Avenue, Po Box 396, Mahnomen, Minnesota 56557 | |
(218) 935-2511 | |
Name | Mahnomen Health Center |
---|---|
Location | 414 West Jefferson Avenue, Po Box 396, Mahnomen, Minnesota |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 32 |
Occupancy Rate | 85.94% |
Medicare ID (CCN) | 245238 |
Legal Business Name | Mahnomen Health Center |
Ownership Type | Government - City/county |
NPI Number | 1710912787 |
Organization Name | MAHNOMEN HEALTH CENTER |
Address | 414 W Jefferson Ave, Mahnomen, MN 56557 |
Phone Number | 218-935-2511 |
News Archive
In low-risk pregnant women, high induction and first-cesarean delivery rates do not lead to improved outcomes for newborns, according to new research published in the April issue of The Journal of Maternal-Fetal and Neonatal Medicine.
The anti-leukemia drug dexamethasone contributes to a relentless fatigue and poor quality of sleep in children undergoing treatment for acute lymphoblastic leukemia (ALL), according to a new study from St. Jude Children's Research Hospital.
People with strokes caused by blood clots fared better in hospitals participating in the Get With The Guidelines-Stroke program according to a study presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2013.
An editorial published this week in the Lancet online highlights the shocking fact that many maternal deaths in the UK are associated with substandard care and are potentially preventable.
The Centre for Brain Research at the MedUni Vienna is regarded as a world leader in researching the mechanisms involved with multiple sclerosis (MS). Now, in a paper published in the highly respected journal Lancet Neurology, an international team of researchers from Edinburgh, Cleveland and Vienna, under the leadership of Hans Lassmann, Head of the Department of Neuroimmunology at the MedUni Vienna, has for the first time documented the pathological progress of the disease from its early to late stage and also shown that inflammatory and neurodegenerative processes have a role to play.
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
In low-risk pregnant women, high induction and first-cesarean delivery rates do not lead to improved outcomes for newborns, according to new research published in the April issue of The Journal of Maternal-Fetal and Neonatal Medicine.
The anti-leukemia drug dexamethasone contributes to a relentless fatigue and poor quality of sleep in children undergoing treatment for acute lymphoblastic leukemia (ALL), according to a new study from St. Jude Children's Research Hospital.
People with strokes caused by blood clots fared better in hospitals participating in the Get With The Guidelines-Stroke program according to a study presented at the American Heart Association's Quality of Care and Outcomes Research Scientific Sessions 2013.
An editorial published this week in the Lancet online highlights the shocking fact that many maternal deaths in the UK are associated with substandard care and are potentially preventable.
The Centre for Brain Research at the MedUni Vienna is regarded as a world leader in researching the mechanisms involved with multiple sclerosis (MS). Now, in a paper published in the highly respected journal Lancet Neurology, an international team of researchers from Edinburgh, Cleveland and Vienna, under the leadership of Hans Lassmann, Head of the Department of Neuroimmunology at the MedUni Vienna, has for the first time documented the pathological progress of the disease from its early to late stage and also shown that inflammatory and neurodegenerative processes have a role to play.
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 14.13 | 14.46 |
Percentage of long-stay residents who lose too much weight | 8.51 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 41.03 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.07 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 3.92 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 6.19 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 10.78 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.02 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 13 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 92.59 | 83.88 |